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Cardiopuimonary bypass is a planned support technique that results in a 
period of myocardial ischemia nd reperfusion. In addition, it is associated 
with an inflammatory esponse likely involving endothelial cell activation. In 
previous tudies, we showed that E-selectin and intercellular adhesion mole- 
cule-I (ICAM.1) messenger ribonucleic acid (mRNA) are increased in human 
myocardium after cardiopulmonary bypass. We have now examined the 
expression of P-selectin mRNA by ribonudease protection in paired atrial 
biopsy specimens from 12 patients before and after cardiopulmonary b pass. 
By means of immunocytochemistry, we have also examined the endothelial cell 
surface expression of P-selectin protein, as well as that of E-selectin and 
ICAM-1 in three additional patients. Patient ages ranged from 1 day to 8.5 
years (median 12 months), and cardiopulmonary b pass times ranged from 46 
to 196 minutes (median 144 minutes). By ribonuclease protection, there was 
marked variability in the expression of P-selectin in biopsy specimens before 
bypass. However, when compared with prebypass levels, P-selectin mRNA 
decreased modestly in 10 of 12 patients after bypass (median decrease 1.5-fold, 
p = 0.016). As seen with immunocytochemistry, P-selectin protein was distrib- 
uted diffusely through the vascular bed on large vessels and small vessels 
before bypass but was virtually absent on capillaries in specimens taken after 
bypass. E-selectin, which was absent in prebypass biopsy specimens, was 
induced in one of the three specimens after bypass, but no change in ICAM-1 
protein expression above baseline was noted. We also find that cultured human 
endothelial cells treated with tumor necrosis factor-a in doses which induce 
ICAM-1 mRNA simultaneously decrease their expression of P-selectin mRNA 
as compared with untreated cells. These observations suggest that endothelial 
P-selectin is transcriptionally downregulated after cardiopulmonary b pass at 
times when E-selectin and ICAM-1 are induced. Furthermore, we find that 
E-selectin and ICAM-1 are expressed at times and at sites where P-selectin is 
absent. Although it is possible that P-selectin may have been induced and lost 
at early times before reperfusion, these data suggest that endothelial P-selectin 
plays a limited role in the inflammatory esponse that ensues after cardiopul- 
monary bypass. (J THORAC CARDIOVASC SURG 1995;110:924-33) 
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C ardiopulmonary bypass is the essential and com- 
mon support echnique used in most cardiovascu- 
lar operations in pediatric patients. During cardiopul- 
monary bypass, the myocardial and pulmonary 
circulations may be interrupted for periods of 1 hour 
or more resulting in profound local ischemia. Reper- 
fusion of ischemic tissue results in cytokine production 
with resultant endothelial activation and leukocyte 
infiltration. 1-3 In addition, cardiopulmonary b pass is a 
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potent inflammatory event involving the activation of 
various humoral cascades 4 and commonly affects mul- 
tiple organs. Usually this multiorgan system dysfunc- 
tion is transient and short-lived, but, in certain in- 
stances, it can be prolonged and severe. Given the 
necessity of cardiopulmonary b pass for reparative 
cardiac operations and its potential for morbidity, we 
have chosen to use it as a human model of inflamma- 
tory injury. Our studies focus on mechanisms whereby 
the endothelium ight contribute to this inflammatory 
response. 
Interactions between circulating leukocytes and 
endothelium have been shown to be critical in inflam- 
matory processes such as ischemia-reperfusion injury. 
A substantial body of evidence suggests that injury 
which follows ischemia results at least in part from the 
local accumulation of neutrophils during reperfu- 
sion. 5-7 This process involves a series of events medi- 
ated by the activation of complementary members of 
several families of adhesion molecules expressed on 
the cell surface of both the leukocyte and the 
endothelial cell. The selectin family of molecules, 
including E-selectin (ELAM-1, CD62E) 8' 9 and P- 
selectin (GMP-140, PADGEM, CD62P), 1°'11 ex- 
pressed by endothelial cells mediate low-affinity 
rolling events by means of interactions with sialy- 
fated oligosaccharides, whereas the integrin family 
of molecules, including LFA-1 (CDlla/CD18) and 
Mac-1 (CDllb/CD18), mediate higher-affinity bind- 
ing by means of interactions with endothelial inter- 
cellular adhesion molecule (ICAM)-I or ICA/V[-2.12-16 
In a previous study, we showed that mRNA for 
E-selectin and ICAM-1 are induced in cardiac and 
skeletal muscle after cardiac operations and car- 
diopulmonary bypass in children. 17 We speculated 
that these molecules, which bind neutrophils, may 
have a role in the pathogenesis of the inflamma- 
tory response after cardiopulmonary b pass. How- 
ever, it is likely that other endothelial adhesion 
molecules also have a role. P-selectin, originally 
described in the alpha-granules of platelets, is also 
expressed by endothelial cells where it is stored 
preformed in Weibel-Palade bodies. 18 After stim- 
ulation of endothelial cells, P-selectin is rapidly 
mobilized to the cell surface where it may bind 
neutrophils, monocytes, and lymphocytes. 1~ In 
vitro, P-selectin has been shown to be functional 
in binding neutrophils within minutes of an initi- 
ating stimulus, ix Thus, as an early participant in 
the adhesive process, P-selectin is an attractive 
target for potential anti-adhesive therapeutic strategies 
in ischemia-reperfusion injury. However, in vivo stud- 
ies using anti-P-selectin antibodies in animal models 
have been somewhat controversial. In some models of 
ischemia-reperfusion anti-P-selectin antibodies ame- 
liorate local inflammation, 19 whereas in others these 
antibodies have no local effect but rather ameliorate 
remote injury. 2° In this human study, we have com- 
pared the expression of myocardial P-selectin mRNA 
in paired biopsy samples before and after cardiopul- 
monary bypass. In addition, we have compared the 
immunocytochemical protein expression of endothe- 
lial P-selectin with E-selectin and ICAM-1 to deter- 
mine site-specific expression of these molecules. 
Patients and methods 
Tissue collection. Tissue was collected in a manner 
similar to that previously described, x7 In brief, samples of 
atrium, skeletal muscle, and skin were obtained from 
pediatric patients undergoing cardiac operations with 
cardiopulmonary bypass for congenital heart disease just 
before onset of cardiopulmonary bypass and after repcr- 
fusion at the conclusion of the surgical procedure. Spec- 
imens were immediately snap frozen in liquid nitrogen 
and stored at -70°C until use. The protocol for tissue 
collection was approved by the Committee on Clinical 
Investigation at Children's Hospital, and informed con- 
sent was obtained for each patient. 
RNA preparation. Total RNA was extracted with the 
guanidinium-thiocyanate method of Chomczynski and 
Sacci 21 with RNAzol B (Cinna/Biotecx, Friendswood, 
Tex.). Quantification of total RNA resuspended in 0.5% 
sodium dodecylsulfate was done with spectrophotometry. 
Antibodies. Monoclonal antibodies used for immuno- 
cytochemistry were SO49 (mouse anti-human P-selec- 
tin) 22 and RR1/1 (mouse anti-human ICAM-1), TM sup- 
plied by T. A. Springer (Boston, Mass.), and H4/18 
(mouse anti-human E-selectin), 8 a gift of M. P. Bevilac- 
qua, Amgen Inc. (Thousand Oaks, Calif.). Antibody 
K16/16 (nonspecific mouse immunoglobulin G) provided 
by D. Menderick (Brigham and Women's Hospital, Bos- 
ton, Mass.) and antihuman CD31 (Dako Corp., Carpen- 
teria, Calif.) served as negative and positive controls, 
respectively. With the exception of CD31, all antibodies 
were used as ascites fluids. Antibodies SO49 and RR1/1 
were titrated at dilutions from 1:1000 to 1:100,000 so that 
changes in staining intensity were easily quantified. Anti- 
body H4/18 was used at a dilution of 1:1000, which 
optimized staining of positive control appendicitis tissue. 
Anti-CD31 antibody was used at a dilution of 1:100. 
Endothelial cell culture. Human umbilical vein endo- 
thelial cells z3 were grown in medium containing 10% fetal 
calf serum, 1% penicillin-streptomycin, L-glutamine, and 
endothelial cell growth factor and were used up to passage 
six. Endothelial cells were treated with human recombi- 
nant tumor necrosis factor (TNF)-a (Boehringer-Mann- 
helm, Indianapolis, Ind.) at a concentration f 100 U/ml 
for 0, 0.5, 1, 2, 6, and 24 hours, and total RNA was 
extracted as described previously. 
Ribonuclease protection assays. Complementary de- 
oxyribonucleic acid templates of human P-selectin and 
9 2 6 Burns et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
October 1995 
3,-actin were chosen to be of different lengths to allow 
multiplex ribonuclease (RNAse) protection analysis on a 
given sample. The full-length P-selectin probe was 366 
base pairs with the protected sequence 303 base pairs in 
length, from base pair 329 to 632 in the full length 
cDNA. TM The selected fragment of P-selectin cDNA (a 
gift of Dr. R. McEver, Oklahoma City, Okla.) was ampli- 
fied by polymerase chain reaction with convenient restric- 
tion sites in the primers and cloned into the BamH1 and 
EcoR1 sites of the plasmid vector, pBluescript II KS 
(Stratagene, La Jolla, Calif.). The P-selectin template was 
linearized with BamHI. All samples were simultaneously 
hybridized with 3,-actin probe z4, 25 which served as an 
internal control. 
All riboprobes were synthesized by runoff transcrip- 
tion with the appropriate RNA polymerase: T3 for 
P-selectin and ICAM-1 antisense probes, and SP6 for 
3,-actin antisense probe as described, z6For each patient 
specimen pair (before and after bypass), equal amounts 
of RNA were analyzed in parallel. Ten micrograms 
of transfer RNA was used as a negative control in 
each experiment. Extracts from cultured human umbil- 
ical vein endothelial cells were analyzed in a similar 
manner. 
Signals were quantified with the ImageQuant software 
(Molecular Dynamics, Sunnyvale, Calif.) after 24-hour 
exposures to Phosphorlmager screens (Molecular Dy- 
namics) and were controlled for background by subtrac- 
tion of the tRNA signal. Each P-selectin band was nor- 
malized for 3,-actin internal control according to the 
formula (P-selectin - P-selectin background)/(3,-actin - 
3,-actin background). Paired postbypass values were com- 
pared with prebypass values, and statistical analysis was 
performed with the Student t test. 
Immunocytochemistry. Four-micrometer cryostat sec- 
tions were air dried for 30 minutes, fixed in acetone for 
5 minutes, then air dried again. Specimens were incu- 
bated in primary antibody then in secondary antibody, 
peroxidase-conjugated goat anti-mouse immunoglobu- 
lin G (Jackson ImmunoResearch, West Grove, Pa.), 
each for 1 hour at room temperature, as described. 27 
The slides were washed in phosphate-buffered saline 
solution/0.2% gelatin between each incubation. Next, 
the slides were incubated in sodium acetate 0.1 mol/L 
(pH 5.2), in 3-amino 9-ethyl carbazole (Sigma Chemical 
Co., St. Louis, Mo.) 12 mg/ml, and in 2% N,N-dimeth- 
ylformamide (Sigma) each for 5 minutes, rinsed in 
deionized water, and counterstained with Gills hema- 
toxylin stain. Finally, the slides were mounted in glyc- 
erol gelatin (Sigma). 
A scoring system was designed to assess the immuno- 
cytochemical staining of specimens. Scores for adhesion 
molecules were based on the qualitative and quantitative 
staining patterns for each molecule compared with posi- 
tive control staining of endothelial-specific anti-CD31 
antibody. The scores ranged from 0 to 4+: 0 = no visible 
stain; 1 = few vessels stained faintly; 2 = moderate 
intensity staining of few vessels; 3 = moderate intensity 
staining of many vessels; and 4 = intense staining of many 
vessels. The slides were scored by three independent 
observers (S. A. B., B. J. D., and D. M. B.). 
Results 
Patients. The patient diagnoses and surgical pro- 
cedures were a mix reflecting the heterogeneity of
congenital heart disease seen at this center and are 
summarized in Table I. Patient ages were 1 day to 
8.5 years (median 12 months). Total cardiopulmo- 
nary support time was 46 to 196 minutes (median 
144 minutes), and the aortic crossclamp was applied 
for 0 to 123 minutes (median 56 minutes). In all 
patients, cardiopulmonary bypass was performed 
under hypothermic conditions. Seven patients had a 
period of deep hypothermic circulatory arrest 
(range 3 to 61 minutes, median 49 minutes) during 
which perfusion of all tissues was interrupted. Spec- 
imens from 12 patients were used for RNA analysis, 
and specimens from three other patients were used 
for immunocytochemistry. 
P-selectin mRNA in human myocardium. P-se- 
lectin mRNA was detected in all samples examined 
before and after bypass and was readily quantified by 
RNAse protection gels (Fig. 1). Marked variability in 
the expression of P-selectin was found in the prebypass 
samples among the 12 paired specimens examined. 
However, P-selectin mRNA expression decreased by a 
modest amount in 10 of 12 paired postbypass speci- 
mens (Fig. 1, A). Overall, the median decrease in 
message was 1.5-fold (range 1.02 to 29.0 fold; Fig. 1, 
A). In one pair of samples, postbypass P-selectin 
mRNA increased slightly above prebypass levels, and, 
in another pair, P-selectin rose twofold. The change in 
P-selectin mRNA was not significantly associated with 
the total support ime, circulatory arrest time, cross- 
clamp time, patient age, or immediate postoperative 
clinical course (data not shown). Thus, it appears that 
P-selectin message, which is constitutively expressed in
human myocardium, may be modestly decreased after 
cardiopulmonary b pass. 
P-selectin protein expression by immunocyto- 
chemistry. Because P-selectin is expressed on other 
cell types in addition to endothelial cells, we next 
wished to confirm that the changes in P-selectin 
mRNA expression oted previously, were reflective 
of changes in endothelial cell P-selectin protein 
expression. In addition, because we have previously 
reported that E-selectin and ICAM-1 mRNA are 
increased after bypass, 17 we wished to evaluate 
whether all three proteins are expressed at different 
times and at different sites within the myocardium 
after bypass. Paired samples of atrium before and 
after bypass from three additional subjects were 
studied with immunocytochemistry for the expres- 
sion of P-selectin, E-selectin, and ICAM-1. The 
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Table I. Patient characteristics 
Patient TST CCT DHCA 
No. Age Diagnosis; procedure (min) (rnin) (min) 
1 4 yr Tetralogy of Fallot, pulmonary atresia; closure of ventricular 190 108 0 
septal defect, right ventricular outflow conduit 
2 5 mo Heterotaxy-polysplenia, secundum atrial septal defect, par- 67 25 0 
tial anomalous pulmonary venous return; repair 
3 5 yr Secundum atrial septal defect; repair 46 22 0 
4 14 days Truncus arteriosus; repair 185 74 33 
5 2.5 yr Heterotaxy-polysplenia with double outlet right ventricle, 139 95 3 
pulmonary stenosis, anomalous pulmonary venous connec- 
tion; repair 
6 4.5 yr Double inlet, single left ventricle, restrictive bulboventricular 196 121 0 
foramen; fenestrated Fontan procedure 
7 7 mo Secundum atrial septal defect, ventricular septal defect, dou- 87 43 0 
ble chambered right ventricle, patent ductus arteriosus; 
repair 
8 1 yr Tetralogy of Fallot; closure of ventricular septal defect, right 150 57 35 
ventricular outflow patch 
9 1 yr Tetralogy of Fallot, pulmonary atresia; closure of ventricular 124 0 61 
septal defect, right ventricular outflow conduit 
10 1 day Double inlet single left ventricle, restrictive bulboventrieular 189 0 58 
foramen, coarctation of the aorta; aortopulmonary anasto- 
mosis, arch reconstruction, Blalock-Taussig shunt 
11 1 yr Sinus venosus atrial septal defect, partial anomalous pulmo- 61 35 0 
nary venous connection, valvar pulmonary stenosis; repair 
12 4 days Transposition of the great arteries, ventricular septal defect; 240 123 60 
arterial switch procedure 
13 2 mo Tetralogy of Fallot; closure of ventricular septal defect, right 152 61 49 
ventricular outflow patch 
14 11 mo Double inlet, single left ventricle, pulmonary stenosis, bilat- 68 0 0 
eral superior vena cavae; bilateral bidirectional cavopul- 
monary anastomoses 
15 8.5 yr Situs inversus totalis, physiologically "corrected" transposi- 92 56 0 
tion of the great arteries, sino-septal trial septal defect, 
left ventricular outflow tract obstruction; closure of sino- 
septal defect, resection left ventricular outflow obstruction 
TST, Total support time; CCT, aortic rossclamp time; DHCA, deep hypothermic circulatory arrest ime. 
results are summarized in Table II. Before bypass, 
P-selectin, and ICAM-1 were expressed constitu- 
tively throughout the vascular bed on all microves- 
sels including capillaries and larger vessels (arte- 
rioles and venules). In contrast, E-selectin was not 
detectable in any of the tissues before the initiation 
of cardiopulmonary b pass. After bypass, the most 
notable finding was a decrease in P-selectin expres- 
sion as compared with prebypass levels. In all spec- 
imens examined, the loss of P-selectin staining was 
most marked on capillaries (Fig. 2, C and D), 
including postcapillary venules. However, the pat- 
tern and intensity of P-selectin staining of larger 
vessels including arterioles and venules was not 
appreciably different between prebypass and post- 
bypass specimens. P-selectin did not change in in- 
tensity in skeletal muscle after cardiopulmonary 
bypass but may have slightly increased in some of 
the postbypass kin specimens. Endothelial ICAM-1 
was expressed iffusely throughout the microvascu- 
lar bed and was not notably different in distribution 
or intensity between prebypass and postbypass pec- 
imens (see Table II and Fig. 2, A and B). E-selectin 
was expressed on an isolated vessel in atrium and 
skin after bypass in one of the three patients exam- 
ined. 
Analysis of P-selectin mRNA in cultured human 
endothelial cells. Because we find that P-selectin 
mRNA is decreased in vivo in endothelial cells, we 
next wished to determine the effect of cytokines on 
P-selectin in cultured human endothelial cells. 
TNF-~ reported to be present in ischemic tissue 
activates endothelial cells in vitro and is reported to 
increase the cell surface expression of endothelial 
928 Burns et aL 
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106 107 111 109 110_ 112 
Fig. 1. P-selectin mRNA levels in atrium from patients 
before and after cardiopulmonary bypass. A, Pho phor- 
Imager quantitation of ribonuclease protection assays for 
patients 1 through 12. The overall median decrease i  
1.5-fold; p = 0.016 with paired t est. ll, Representative 
autoradiograph of RNAse protection experiment with pairs 
of atrial tissue. The expected P-selectin protected band (303 
nucleotides) and 3,-actin control band (140 nucleotides) are 
shown with bold arrows. The small arrow above P-selectin 
indicates a nonspecific band which was lso present in the 
tRNA negative control lane. 
P_selectin.2, 3, 28-30 We performed RNAse protection 
assays on RNA extracted from cultured human 
endothelial cells after treatment with TNF-a and 
examined the expression of P-selectin and ICAM-1 
mRNA. We find that P-selectin mRNA, present in 
untreated human endothelial cells, was somewhat 
decreased by 6 hours and was markedly decreased at 
24 hours after treatment with TNF-a (Fig. 3). In 
contrast, ICAM-1 message increased as early as 1 
hour after stimulation, peaked at 6 hours after 
stimulation, and, although still increased above 
basal levels, had decreased by 24 hours. (Fig. 3). 
These in vitro findings confirm that human endothe- 
lial P-selectin may be transcriptionally downregu- 
lated after activation of endothelial cells with 
TNF-a in doses which stimulate ICAM-1 mRNA. 
Discussion 
The use of cardiopulmonary bypass for cardiac 
operations in pediatric patients is common, and in 
Table II. Scores for immunocytochemical 
expression of endothelial cell P-selectin, E-selectin, 
and ICAM-1 
Atrium Muscle Slan 
Pre Post Pre Post Pre Post 
P-selectin 2 1 * 2 2 2 3 
E-selectin 0 1 0 0 0 1 
ICAM-1 2 2 2 2 2 3 
Pre, Before cardiopulmonary b pass; Post, after cardiopulmonary b pass. 
*Loss of staining noted on capillaries only; staining of venules and 
arterioles did not appreciably change. 
most cases is essential for successful cardiac opera- 
tions. In addition to the widespread "total body 
inflammation" associated withcardiopulmonary b - 
pass, 4the myocardium ay be subjected to periods 
of ischemia resulting in detrimental events including 
local inflammation and tissue injury. Although the 
resultant ischemia-reperfusion inflammatory injury 
is usually mild and transient, it may be severe and 
thereby increase the morbidity and mortality after 
the surgical procedure. In this study, we have used 
this human model involving planned periods of 
ischemia and reperfusion to examine patterns of 
endothelial adhesion molecule xpression. We find 
that P-selectin mRNA and protein are decreased 
after cardiopulmonary bypass, likely a result of a 
diminution in endothelial cell P-selectin. We also 
find that endothelial E-selectin and ICAM-1 may be 
expressed at times and at sites where P-selectin 
expression is decreased or absent. 
An important question raised by this study is 
whether endothelial P-selectin has a role in the 
inflammatory process induced by ischemia-reperfu- 
sion in human beings. P-selectin is rapidly trans- 
ported from endothelial cell storage granules to the 
cell surface where it binds neutrophils to mediate 
adhesion events and "rolling" in a shear ate-depen- 
dent manner. 31' 32 The rapidity of P-selectin redis- 
tribution and loss from endothelial cell surfaces 
(within minutes) led to the prediction that func- 
tional P-selectin events occur early and transiently. 33
Indeed, our finding of decreased P-selectin expres- 
sion at least 1 hour after injury is consistent with 
these studies. Although we did not examine myocar- 
dial biopsy specimens at early times, it is possible 
that endothelial P-selectin may have been expressed 
and lost before the onset of reperfusion. Neverthe- 
less, because neutrophil recruitment and associated 
inflammation occur during the period of reperfu- 
sion, our data suggest hat there may be a limited 
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Fig. 2. Immunocytochemical st ining of atrial tissue before (Pre) and after (Post) cardiopulmonary bypass 
from one patient. A (original magnification x400): prebypass atrium stained for ICAM-1 shows diffuse, 
constitutive expression of ICAM-1. B (x400): postbypass atrium stained for ICAM-1 showing a similar 
staining pattern as that in A. C (×400): prebypass atrium showing endothelial P-selectin on a moderate 
number of small and larger vessels. D (x400): postbypass atrium showing a significant loss of taining of 
capillary P-selectin as compared with C. Note that staining of larger vessels did not appreciably change. E 
(x 1000): higher power of the prebypass specimen in C showing endothelial cell expression f P-selectin. 
role for P-selectin in subsequent neutrophil recruit- 
ment. This suggestion has been tested by Seekamp 
and associates 2°in a rabbit limb ischemia model in 
which anti-P-selectin antibodies failed to ameliorate 
local reperfusion injury (1 hour ischemia, 1.5 hours 
reperfusion). 
Other studies in animal models have shown that 
anti-P-selectin antibodies may decrease the reper- 
fusion inflammatory response. 34' 3s Several possi- 
bilities exist for the observed ifferences between 
these animal studies and the current study. First, 
human cardiopulmonary b pass may not be a pure 
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Fig. 3. Time course ofP-selectin and ICAM-1 mRNA in human umbilical vein endothelial cells treated 
with TNF-a. Endothelial cells were treated with human recombinant TNF-c~ (100 U/ml) and total RNA 
extracted. Ribonuclease protection assays were quantified with Phosphorlmager screens. A shows the 
results of two experiments. B shows the autoradiograph of RNAse protection assay from experiment 2. 
Each time point was performed in duplicate. (Note: the single solid triangle in experiment 2 indicates 
P-selectin mRNA level in cells exposed to TNF-a briefly ("TNF wash"), and time 0 hr P-selectin and 
ICAM-1 represent cells exposed to medium only). 
ischemia-reperfusion phenomenon. It involves ex- 
posure of the circulating leukocytes to foreign 
surfaces in the bypass circuit, which may activate 
neutrophils and enhance their ability to localize 
within microvascular tissue beds. Second, the de- 
gree of ischemia suffered by the heart during 
bypass procedures may be much less with use of 
protective hypothermia and myocardial protective 
infusions of cardioplegic solution, than that in- 
duced by vessel clamping in experimental isch- 
emia-reperfusion models. Third, P-selectin func- 
tion may vary with changes in the shear flow rate, 
evident in various vascular beds under different 
experimental conditions. 31' 3z, 36 Fourth, interspe- 
cies differences may exist in the expression of 
P-selectin. For instance, we find that TNF-a 
downregulates P-selectin transcription i cultured 
human endothelial cells at times when it has been 
reported to induce P-selectin mRNA in mouse 
endothelial cells. 29 
Cell surface expression of P-selectin may be 
regulated at several levels, including transcrip- 
tional control of synthesis of the protein or regu- 
lation of the expressed cell surface protein. P- 
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selectin protein may be lost into the circulation, 
reinternalized and degraded, or reinternalized 
and returned to intracellular storage granules. 
Our analysis uggests that transcriptional control 
of P-selectin is unlikely. We observed that total 
P-selectin mRNA levels from extracts of atrium 
decrease only slightly at times when microvascular 
protein appears to decrease substantially. In ad- 
dition, our findings that P-selectin mRNA de- 
creases in activated cultured endothelial cells at 
times when cell surface expression is present (6 
hours) 3° suggests that the predomlnant regulatory 
mechanism is not likely to be at the level of de 
novo synthesis. Regulation of P-selectin may be at 
the level of the protein itself because rapid rein- 
ternalization of P-selectin is seen in activated 
endothelial cells, u The fate Of the reinternalized 
P-selectin is controversial. Green and associates 37
have shown that loss of P-selectin from the sur- 
face of transfected PC 12 and CHO cells is most 
likely due to internalization followed by rapid 
lysosomal degradation of P-selectin protein. Sub- 
ramanian, Koedam, and Wagner as have suggested 
that a substantial portion of P-selectin surface 
protein which is reinternalized reappears in Wei- 
bel-Palade bodies and is thus "recycled". 38Recy- 
cling of P-selectin would not account for our 
observation of the absolute loss of P-selectin staining 
from capillaries at early times. Furthermore, Silber 
and associates 39 noted that P-selectin protein which 
fell to low amounts by 24 hours did not return to 
baseline constitutive l vels until 72 hours, suggesting 
that P-selectin is degraded and later synthesized de 
novo rather than recycled. 39 
In this study, we find that ICAM-1 protein is 
constitutively expressed on endothelium in both 
prebypass and postbypass specimens. In addition, 
we find that E-selectin, which was not present on 
endothelial cells in prebypass specimens, was ex- 
pressed on an isolated vessel in one postbypass 
atrial specimen. These immunohistochemical 
findings are consistent with our previous report in 
which we found that ICAM-1 and E-selectin 
mRNA had increased in most postbypass speci- 
mens. 17 The earliest time course for maximal 
E-selectin and ICAM-1 protein expression i  vivo 
is 2 hours and 9 hours, respectively, after an 
inflammatory stimulus. 27 Thus, it is likely that the 
postbypass pecimens used in this study were 
obtained too early to detect any significant 
amounts of cell surface E-selectin and ICAM-1 
protein expression. 
In summary, we find that both endothelial P- 
selectin mRNA and protein expression are de- 
creased in human myocardium after cardiopulmo- 
nary bypass. Although P-selectin may have been 
expressed at early times (minutes) during the 
period of ischemia nd had decreased by the time 
of postbypass biopsy and analysis, our observa- 
tions suggest endothelial P-selectin has a limited 
role in subsequent myocardial tissue injury. More- 
over, the expression of E-selectin and ICAM-1 
suggests a role for these molecules in the inflam- 
matory process after bypass. Future studies to 
further elucidate the mechanisms underlying car- 
diopulmonary bypass-related tissue injury will ul- 
timately lead to new therapeutic strategies to 
improve the clinical outcome of children under- 
going cardiac operations. 
We thank R. S. Cotran, MD, for his critical review of 
this manuscript and Amy Walsh, RN, for her assistance 
with patient information and samples. 
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